NASDAQ:ATYR | Free Cash Flow | aTYR PHARMA INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$12.52M$138,000.00-$12.66M
2025-12-31-$12.2M$31,000.00-$12.23M
2025-03-31-$15.42M$0.00-$15.42M
2024-12-31-$13.13M$25,000.00-$13.16M
2024-03-31-$22.38M$17,000.00-$22.4M
2023-12-31-$11.06M$17,000.00-$11.08M
2023-03-31-$590,000.00$1.25M-$1.84M
2022-12-31-$10.37M$1.12M-$11.49M
2022-03-31-$10.12M$43,000.00-$10.16M
2021-12-31-$8.09M$18,000.00-$8.1M
2021-03-31-$5.83M$17,000.00-$5.84M
2020-12-31-$5.4M$5,000.00-$5.41M
2020-03-31$2.06M$166,000.00$1.89M107.93%
2019-12-31-$4.92M$41,000.00-$4.96M-352.56%
2019-03-31-$6.02M$10,000.00-$6.03M
2018-12-31-$4.84M$9,000.00-$4.85M
2018-03-31-$10.58M$498,000.00-$11.08M
2017-12-31-$10.31M$160,000.00-$10.47M
2017-03-31-$13.89M$262,000.00-$14.15M
2016-12-31-$11.7M$46,000.00-$11.74M
2016-03-31-$12.49M$314,000.00-$12.81M
2015-12-31-$9.84M$119,000.00-$9.95M
2015-03-31-$6.29M$123,000.00-$6.41M
2014-12-31-$5.8M$0.00-$5.8M
2014-03-31-$6.35M$211,000.00-$6.56M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$61.99M$77,000.00-$62.06M
2024-12-31-$69.12M$65,000.00-$69.18M
2023-12-31-$33.22M$4.22M-$37.44M
2022-12-31-$41.89M$1.64M-$43.53M
2021-12-31-$33.08M$192,000.00-$33.27M
2020-12-31-$15.3M$202,000.00-$15.5M
2019-12-31-$20.01M$79,000.00-$20.09M
2018-12-31-$31.06M$594,000.00-$31.66M
2017-12-31-$42.36M$1.31M-$43.68M
2016-12-31-$52.86M$600,000.00-$53.46M
2015-12-31-$36.8M$664,000.00-$37.46M
2014-12-31-$22.82M$249,000.00-$23.07M
2013-12-31-$17.31M$644,000.00-$17.96M